A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Type 2 Diabetes Mellitus
Related studies linked through entity extraction aliases.
RCT Examining Effects of Probiotics in T2DM Individuals
- Status
- UNKNOWN
- Phase
- NA
Lifestyle Intervention With an Interactive Video Game for Type 2 Diabetes Patients
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Effect of Vitamin D Supplementation on Glucose Tolerance in Subjects at Risk for Diabetes With Low Vitamin D.
- Status
- COMPLETED
- Phase
- PHASE2
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Obesity Treatments on Food Preferences and Metabolism
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)
- Status
- COMPLETED
- Phase
- PHASE3
Nitrate and Exercise-induced Cardiac Troponin T in Type 2 Diabetes
- Status
- UNKNOWN
- Phase
- NA
A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)
- Status
- COMPLETED
- Phase
- PHASE4
Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin
- Status
- UNKNOWN
- Phase
- NA
Diabetes in India Nutrition Guidelines Study (DINGS)
- Status
- COMPLETED
- Phase
- NA
Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
- Status
- COMPLETED
- Phase
- PHASE3
Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
- Status
- COMPLETED
- Phase
- PHASE3
Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3